See also this year's filing and all EDGAR filings for this company.
PDF Report 0001626199_2019_Alpine_Immune_Sciences_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Immune Design CORP', 'shared_tokens': {'immune'}}]} |
Graph
Absolute values for 0001626199, Alpine Immune Sciences INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 53,545,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 1,196,000 |
| 3 | remainder_Assets | 132,000 |
| 4 | LiabilitiesCurrent | 8,127,000 |
| 5 | LiabilitiesNoncurrent | 2,155,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 8,438,977 |
| 9 | ResearchAndDevelopmentExpense | 23,253,424 |
| 10 | remainder_Expenses | -48,000 |
| 11 | remainder_Revenues | 9,291,735 |
| 12 | remainder_NetIncome | 8,175,081 |
| 13 | remainder_ComprehensiveNetIncome | -58,613 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 54,873,000 |
| 1 | Liabilities | 10,282,000 |
| 2 | Expenses | 31,644,401 |
| 3 | Revenues | 9,291,735 |
| 4 | StockholdersEquity | 44,591,000 |
| 5 | NetIncome | -14,177,585 |
| 6 | ComprehensiveNetIncome | -14,206,892 |
| 7 | BaseVar | 57,162,415 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.55 |
| 9 | EconomicCapitalRatio | 3.39 |
Edgar->Model Mapping
Feature Distribution
Change over Time
